Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Autor: Gerstein HC (AUTHOR), Yusuf S (AUTHOR), Bosch J (AUTHOR), Pogue J (AUTHOR), Sheridan P (AUTHOR), Dinccag N (AUTHOR), Hanefeld M (AUTHOR), Hoogwerf B (AUTHOR), Laakso M (AUTHOR), Mohan V (AUTHOR), Shaw J (AUTHOR), Zinman B (AUTHOR), Holman RR (AUTHOR), DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators (CORPORATE AUTHOR), Gerstein, H C (AUTHOR), Yusuf, S (AUTHOR), Bosch, J (AUTHOR), Pogue, J (AUTHOR), Sheridan, P (AUTHOR), Dinccag, N (AUTHOR)
Zdroj: Lancet. 9/23/2006, Vol. 368 Issue 9541, p1096-1105. 10p.
Databáze: Academic Search Ultimate